Hinge Bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$30M

Hinge Bio is a biotechnology company developing multivalent, multispecific antibody-based therapeutics for autoimmune, inflammatory, infectious diseases, and cancer.

Total Funding

$30M

Headquarters

Burlingame, USA

Founded

N/A

Website

hingebio.com

Focus Areas

Biotechnology

Antibody-based therapeutics

Autoimmune diseases

Inflammatory diseases

Infectious diseases

Cancer

Investors